FREQUENTLY ASKED QUESTIONS
Questions about working with Synprecia
Clear answers about our role, engagement models, confidentiality and external-provider coordination.
Synprecia is an independent preclinical development and coordination partner. Depending on the assignment, support may be provided directly or coordinated through selected CROs, laboratories and subject-matter experts. Synprecia is not represented as owning laboratory facilities.
Support may begin during early planning, candidate evaluation, proof-of-concept work, outsourced study coordination, development-readiness assessment or review of an existing program.
Yes. An engagement may focus on one protocol, provider selection, dataset or defined study. Broader program support is also possible.
Synprecia can identify potential providers, prepare requests for proposal, compare technical approaches and coordinate selected contributors within an agreed scope.
Synprecia may support scientific organisation of preclinical evidence. Formal regulatory, legal or jurisdiction-specific advice must be confirmed within scope and obtained from qualified specialists where appropriate.
Yes. Synprecia can assess scientific design, assumptions, exclusions, deliverables, timing, dependencies and overall suitability.
Yes. A troubleshooting engagement can review design, execution, controls, exposure, assay performance, model suitability and interpretation before recommending whether to repeat, redesign or redirect.
Yes. The flexible model helps emerging companies access experienced preclinical support without creating every capability internally.
Synprecia may provide independent scientific due diligence on rationale, evidence quality, assumptions, gaps and risks. This is not legal, investment or financial advice.
It normally begins with a non-confidential introductory discussion. Confidentiality, scope, deliverables, timing and commercial terms are then agreed before detailed work begins.
No. The public form is for non-confidential introductory information only. Appropriate arrangements can be established before sensitive documents are exchanged.
Use the contact form or email Business Development at bd@synprecia.com.